Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Sales | 7,680 | 2,273 | 8,030 | 4,200 | 4,074 |
| Cost of Goods | 7,101 | 1,892 | 6,497 | 4,818 | 3,915 |
| Gross Profit | 580 | 382 | 1,533 | -618 | 159 |
| Operating Expenses | 5,023 | 3,801 | 4,514 | 7,711 | 16,960 |
| Operating Income | -4,342 | -2,528 | -2,484 | -7,512 | -15,886 |
| Interest Expense | 286 | 292 | 419 | 984 | 1,395 |
| Other Income | -50 | -223 | 271 | 777 | 372 |
| Pre-tax Income | -4,678 | -3,043 | -2,633 | -7,718 | -16,910 |
| Income Tax | -5 | 0 | -365 | 173 | 4,100 |
| Net Income Continuous | -4,673 | -3,043 | -2,267 | -7,891 | -21,010 |
| Minority Interests | -69 | -20 | -15 | -139 | -769 |
| Net Income | $-4,614 | $-3,023 | $-2,252 | $-7,752 | $-20,241 |
| EPS Basic Total Ops | -0.31 | -0.37 | -0.32 | -2.66 | -13.40 |
| EPS Basic Continuous Ops | -0.32 | -0.37 | -0.33 | -2.71 | -13.91 |
| EPS Diluted Total Ops | -0.31 | -0.37 | -0.32 | -2.66 | -13.40 |
| EPS Diluted Continuous Ops | -0.32 | -0.37 | -0.33 | -2.71 | -13.91 |
| EBITDA(a) | $-3,561 | $-1,815 | $-1,509 | $-6,515 | $-9,308 |